At Naturesactiv Global Pvt. Ltd., I conducted research in applied biotechnology and natural product analysis, gaining hands-on exposure to laboratory protocols and product development pipelines.
My research has applied computational methods to investigate natural compounds and biological targets, including PARP-1, PPAR-γ, and MPS1/TTK kinase. I used molecular docking and molecular dynamics analysis in this work.
I filed a patent on inhibiting key Plasmodium falciparum proteins via molecular docking for antimalarial drug discovery. My research on luteolin and pedalitin as potential MPS1/TTK kinase-targeting scaffolds also explored natural compounds as potential anticancer agents.
I received the 2nd Prize – Best Oral Presentation Award at BIOCOM 2026 for research on a thermostable α-carbonic anhydrase mutant. My training and project work include bioinformatics, computational biology, and computer-aided drug design.
